 | Up a level |
Journal Article
Trub, Marta, Uhlenbrock, Franziska, Claus, Christina, Herzig, Petra, Thelen, Martin 
ORCID: 0000-0002-2785-9726, Karanikas, Vaios, Bacac, Marina, Amann, Maria, Albrecht, Rosemarie, Ferrara-Koller, Claudia, Thommen, Daniela, Rothschield, Sacha, Prince, Spasenija Savic, Mertz, Kirsten D., Cathomas, Gieri, Rosenberg, Robert, Heinzelmann-Schwarz, Viola, Wiese, Mark, Lardinois, Didier, Umana, Pablo, Klein, Christian ORCID: 0000-0001-7594-7280, Laubli, Heinz, Kashyap, Abhishek S. and Zippelius, Alfred
(2020).
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer.
J. Immunother. Cancer, 8 (2).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2051-1426
Hassenrueck, Floyd, Knoedgen, Eva, Goeckeritz, Elisa, Midda, Safi Hasan ORCID: 0000-0002-2822-6293, Vondey, Verena, Neumann, Lars, Herter, Sylvia, Klein, Christian ORCID: 0000-0001-7594-7280, Hallek, Michael and Krause, Guenter
(2018).
Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors.
Biomed Res. Int., 2018.
LONDON:
HINDAWI LTD.
ISSN 2314-6141
Goeckeritz, Elisa, Kerwien, Susan, Baumann, Michael, Wigger, Marion, Vondey, Verena, Neumann, Lars, Landwehr, Thomas, Wendtner, Clemens M., Klein, Christian ORCID: 0000-0001-7594-7280, Liu, Ningshu, Hallek, Michael, Frenzel, Lukas P. and Krause, Guenter
(2015).
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Int. J. Cancer, 137 (9).
S. 2234 - 2243.
HOBOKEN:
WILEY-BLACKWELL.
ISSN 1097-0215
Goede, Valentin, Klein, Christian ORCID: 0000-0001-7594-7280 and Stilgenbauer, Stephan
(2015).
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody.
Oncol. Res. Treat., 38 (4).
S. 185 - 193.
BASEL:
KARGER.
ISSN 2296-5262
Goede, Valentin, Klein, Christian ORCID: 0000-0001-7594-7280 and Stilgenbauer, Stephan
(2015).
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody.
Oncol. Res. Treat., 38 (4).
S. 185 - 193.
BASEL:
KARGER.
ISSN 2296-5262
Kobold, Sebastian, Steffen, Julius, Chaloupka, Michael, Grassmann, Simon, Henkel, Jonas, Castoldi, Raffaella, Zeng, Yi, Chmielewski, Markus, Schmollinger, Jan C., Schnurr, Max, Rothenfusser, Simon, Schendel, Dolores J., Abken, Hinrich, Sustmann, Claudio, Niederfellner, Gerhard, Klein, Christian ORCID: 0000-0001-7594-7280, Bourquin, Carole ORCID: 0000-0003-3862-4583 and Endres, Stefan
(2015).
Selective Bispecific T Cell Recruiting Antibody and Antitumor Activity of Adoptive T Cell Transfer.
JNCI-J. Natl. Cancer Inst., 107 (1).
CARY:
OXFORD UNIV PRESS INC.
ISSN 1460-2105